Ashwani Gujral of ashwanigujral.com told CNBC-TV18, "You are best to exit Glenmark Pharma and get into some of the current favorites, maybe Reliance Industries, Tata Steel, any of those stocks could do much better here. So my advice is exit out of Glenmark.”
Glenmark Pharma ended at Rs 613.50, up Rs 2.10, or 0.34 percent on the BSE.
The share touched its 52-week high Rs 993 and 52-week low Rs 567.95 on 01 November, 2016 and 12 September, 2017, respectively.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!